University of Calgary Creates Canada’s First Chair for Psychedelic Research
Canada gets its first chair for psychedelic research thanks to private citizen funding to the University of Calgary.
Author: Jennifer Walker-Journey
80 to 100% of Amputees Experience Phantom Limb Syndrome. Psilocybin May Help.
New research into psychedelics shows psilocybin may help amputees suffering from pain associated with phantom limb syndrome.
Psychedelic Business Spotlight: June 11, 2021
This week in psychedelic business news: An all-female biotech company, psychedelic-assisted psychotherapy for COVID front-liners, and more.
First-of-Its-Kind Genetic Psychedelic Test Kit Now Available In U.S.
The first genetic psychedelic test kit is now available in the U.S. The kits are designed to help users know how they’ll respond to psychedelics.
Seattle Council Tasks Drug Overdose Panel With Exploring Decriminalizing Psychedelics
Seattle city council members are being asked to review decriminalizing psychedelics.
Psilocybin Shows Promise As Treatment for Migraines
A new investigation into treatment for migraines spotlights the psychedelic psilocybin mushroom as a promising prospect.
Connecticut Governor Signs Psychedelic Reform Deal
Connecticut has become the newest state to consider reform proposals regarding psychedelic medicines.
Cybin Launches First Clinical Trial to Treat Frontline Workers Experiencing COVID-Related Distress With Psychedelics
A new first-of-its-kind psychedelic study will treat frontline workers experiencing distress related to COVID with psilocybin.
Field Trip Health Begins Trading on TSE, Sets Sights on Nasdaq
Psychedelic lifestyle brand Field Trip Health is now trading on the Toronto Stock Exchange under the symbol “FTRP”.
GH Research Is Taking Psychedelic 5-MeO-DMT ‘Toad Venom’ Public
GH Research is taking its psychedelic 5-MeO-DMT public on the Nasdaq with an IPO valued at more than $100 million.
End of content
End of content